Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:10 pm Purchase | 2020-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX | Redmile Group, LLC | 209,783 9.900% | 209,783 (New Position) | Filing History |
| 2021-02-16 4:10 pm Purchase | 2020-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Redmile Group, LLC | 2,720,489 6.100% | 2,720,489 (New Position) | Filing History |
| 2021-02-16 4:10 pm Sale | 2020-12-31 | 13G | ImmunoGen, Inc. IMGN | Redmile Group, LLC | 10,528,179 5.600% | -4,111,781 (-28.09%) | Filing History |
| 2021-02-16 4:10 pm Purchase | 2020-12-31 | 13G | HOOKIPA Pharma Inc. HOOK | Redmile Group, LLC | 265,390 9.900% | 76,138 (+40.23%) | Filing History |
| 2021-02-16 4:10 pm Purchase | 2020-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Redmile Group, LLC | 4,915,729 9.900% | 1,799,135 (+57.73%) | Filing History |
| 2021-02-16 4:10 pm Purchase | 2020-12-31 | 13G | Epizyme, Inc. EPZM | Redmile Group, LLC | 10,225,405 9.900% | 1,088,032 (+11.91%) | Filing History |
| 2021-02-16 4:09 pm Purchase | 2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Redmile Group, LLC | 314,545 9.900% | 94,780 (+43.13%) | Filing History |
| 2021-02-16 4:09 pm Purchase | 2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Redmile Group, LLC | 2,416,406 6.000% | 2,416,406 (New Position) | Filing History |
| 2021-02-16 4:09 pm Purchase | 2020-12-31 | 13G | Yumanity Therapeutics, Inc. YMTX | Redmile Group, LLC | 96,221 6.600% | 96,221 (New Position) | Filing History |
| 2021-02-16 4:09 pm Sale | 2020-12-31 | 13G | Wave Life Sciences Ltd. WVE | Redmile Group, LLC | 79,018 0.200% | -3,247,475 (-97.62%) | Filing History |
| 2021-02-16 4:09 pm Sale | 2020-12-31 | 13G | uniQure N.V. QURE | Redmile Group, LLC | 1,028,898 2.300% | -1,524,427 (-59.70%) | Filing History |
| 2021-02-16 4:09 pm Purchase | 2020-12-31 | 13G | TCR2 Therapeutics Inc. TCRR | Redmile Group, LLC | 2,832,888 8.500% | 1,033,700 (+57.45%) | Filing History |
| 2021-02-16 4:09 pm Purchase | 2020-12-31 | 13G | Stoke Therapeutics, Inc. STOK | Redmile Group, LLC | 2,686,234 7.400% | 2,686,234 (New Position) | Filing History |
| 2021-02-16 4:08 pm Purchase | 2020-12-31 | 13G | Stereotaxis, Inc. STXS | Redmile Group, LLC | 7,833,765 9.900% | 780,303 (+11.06%) | Filing History |
| 2021-02-16 4:08 pm Purchase | 2020-12-31 | 13G | Scholar Rock Holding Corporation SRRK | Redmile Group, LLC | 3,412,009 9.900% | 471,120 (+16.02%) | Filing History |
| 2021-02-16 4:08 pm Sale | 2020-12-31 | 13G | REGENXBIO Inc. RGNX | Redmile Group, LLC | 2,123,492 5.700% | -384,894 (-15.34%) | Filing History |
| 2021-02-16 4:08 pm Sale | 2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group, LLC | 3,388,376 9.600% | -22,281 (-0.65%) | Filing History |
| 2021-02-16 4:08 pm Purchase | 2020-12-31 | 13G | Krystal Biotech, Inc. KRYS | Redmile Group, LLC | 1,675,036 8.500% | 584,836 (+53.64%) | Filing History |
| 2021-02-16 4:07 pm Purchase | 2020-12-31 | 13G | GENMARK DIAGNOSTICS INC GNMK | Redmile Group, LLC | 4,537,400 6.300% | 4,537,400 (New Position) | Filing History |
| 2021-02-16 4:07 pm Sale | 2020-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Redmile Group, LLC | 4,437,968 7.800% | -271,530 (-5.77%) | Filing History |